Flynn James E

Larimar Therapeutics, Inc. · Director, other* Director by Deputization, 10% Owner

Flynn James E is listed in public filings as director, 10 percent owner, other: * Director by Deputization. This Flynn James E insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Larimar Therapeutics, Inc. (LRMR), Nuvalent, Inc. (NUVL), ARS Pharmaceuticals, Inc. (SPRY), BiomX Inc. (PHGE), and Bicara Therapeutics Inc. Common Stock (BCAX). Investors use Flynn James E's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Larimar Therapeutics, Inc.LRMR	$184k55.2k shares	Grant / ExerciseMay 19, 2026	$183.7K55.2k shares	$3.33	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Larimar Therapeutics, Inc.LRMR	$31M6.2M shares	BuyFeb 27, 2026	$10.0M2M shares	$5.00	--
Larimar Therapeutics, Inc.LRMR	$53M10.6M shares	BuyFeb 27, 2026	$5.4M1.1M shares	$5.00	--
Larimar Therapeutics, Inc.LRMR	$53M10.6M shares	BuyFeb 27, 2026	$5.4M1.1M shares	$5.00	--
Larimar Therapeutics, Inc.LRMR	$41M8.2M shares	BuyFeb 27, 2026	$4.2M832k shares	$5.00	--
Nuvalent, Inc.NUVL	$792M8.3M shares	SellNov 24, 2025	$35.4M371.3k shares	$95.45	--
Larimar Therapeutics, Inc.LRMR	$31M9.5M shares	BuyJul 31, 2025	$10.8M3.4M shares	$3.20	--
Larimar Therapeutics, Inc.LRMR	$31M9.5M shares	BuyJul 31, 2025	$10.8M3.4M shares	$3.20	--
Larimar Therapeutics, Inc.LRMR	$23M7.3M shares	BuyJul 31, 2025	$8.3M2.6M shares	$3.20	--
ARS Pharmaceuticals, Inc.SPRY	$90M4.9M shares	SellJun 27, 2025	$6.8M370.1k shares	$18.46	--
Larimar Therapeutics, Inc.LRMR	$36k19k shares	Grant / ExerciseMay 13, 2025	$35.6K19k shares	$1.88	--
BiomX Inc.PHGE	$1.5M1.6M shares	Grant / ExerciseApr 21, 2025	$1.5M1.6M shares	$0.9306	--
BiomX Inc.PHGE	$9.5k17.6k shares	Grant / ExerciseApr 14, 2025	$9.5K17.6k shares	$0.538	--
BiomX Inc.PHGE	$1.2M1.2M shares	Grant / ExerciseFeb 27, 2025	$328.7K353.2k shares	$0.9306	--
BiomX Inc.PHGE	--405.6k shares	Grant / ExerciseFeb 27, 2025	Disclosure amount unavailable1.6M shares	--	--
BiomX Inc.PHGE	--1.3M shares	Grant / ExerciseFeb 27, 2025	Disclosure amount unavailable1.3M shares	--	--
ARS Pharmaceuticals, Inc.SPRY	$93M5.3M shares	SellNov 12, 2024	$169.8K9.6k shares	$17.77	--
ARS Pharmaceuticals, Inc.SPRY	$93M5.3M shares	SellNov 12, 2024	$169.8K9.6k shares	$17.77	--
ARS Pharmaceuticals, Inc.SPRY	$90M5.3M shares	SellNov 12, 2024	$134.8K7.9k shares	$17.16	--
ARS Pharmaceuticals, Inc.SPRY	$90M5.3M shares	SellNov 12, 2024	$134.8K7.9k shares	$17.16	--
ARS Pharmaceuticals, Inc.SPRY	$96M5.3M shares	SellNov 11, 2024	$4.1M223.6k shares	$18.15	--
ARS Pharmaceuticals, Inc.SPRY	$96M5.5M shares	SellNov 11, 2024	$708.4K40.6k shares	$17.45	--
Bicara Therapeutics Inc. Common StockBCAX	$16M897.6k shares	BuySep 17, 2024	$630.0K35k shares	$18.00	--
Bicara Therapeutics Inc. Common StockBCAX	--8M shares	Grant / ExerciseSep 17, 2024	Disclosure amount unavailable8M shares	--	--
Bicara Therapeutics Inc. Common StockBCAX	--862.6k shares	Grant / ExerciseSep 17, 2024	Disclosure amount unavailable862.6k shares	--	--
BiomX Inc.PHGE	--48k shares	Grant / ExerciseJul 15, 2024	Disclosure amount unavailable5.9k shares	--	--
BiomX Inc.PHGE	--8.9M shares	Grant / ExerciseJul 15, 2024	Disclosure amount unavailable5.9M shares	--	--
BiomX Inc.PHGE	$96k264k shares	Grant / ExerciseJul 11, 2024	$95.8K264k shares	$0.363	--
BiomX Inc.PHGE	$4.7M20.2M shares	Grant / ExerciseJul 9, 2024	$4.7M20.2M shares	$0.2311	--
BiomX Inc.PHGE	$3.6M722.2k shares	Grant / ExerciseJul 9, 2024	$3.6M722.2k shares	$5.00	--